Abstract:Background: Ferroptosis is a nonapoptotic cell death process that is characterized by lipid peroxidation and intracellular iron accumulation. As osteoarthritis (OA) progresses, inflammation or iron overload induces fer-roptosis of chondrocytes. However, the genes that play a vital role in this process are still poorly studied.Methods: Ferroptosis was elicited in the ATDC5 chondrocyte cell line and primary chondrocytes by administration of the proinflammatory cytokines, interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha, which play key roles in OA. The effect of FOXO3 expression on apoptosis, extracellular matrix (ECM) metabolism, and ferroptosis in ATDC5 cells and primary chondrocytes was verified by western blot, Immunohistochemistry (IMHC), immuno-fluorescence (IF) and measuring Malondialdehyde (MDA) and Glutathione (GSH) levels. The signal cascades that modulated FOXO3-mediated ferroptosis were identified by using chemical agonists/antagonists and lentivirus. In vivo experiments were performed following destabilization of medial meniscus surgery on 8-week-old C57BL/6 mice and included micro-computed tomography measurements.Results: In vitro administration of IL-1 beta and TNF-alpha, to ATDC5 cells or primary chondrocytes induced ferroptosis. In addition, the ferroptosis agonist, erastin, and the ferroptosis inhibitor, ferrostatin-1, downregulated or upregulated the protein expression of forkhead box O3 (FOXO3), respectively. This, suggested, for the first time, that FOXO3 may regulate ferroptosis in articular cartilage. Our results further suggested that FOXO3 regulated ECM metabolism via the ferroptosis mechanism in ATDC5 cells and primary chondrocytes. Moreover, a role for the NF-kappa B/mitogen-activated protein kinase (MAPK) signaling cascade in regulating FOXO3 and ferroptosis was demonstrated. In vivo experiments confirmed the rescue effect of intra-articular injection of a FOXO3-overexpressing lentivirus against erastin-aggravated OA. Conclusions: The results of our study show that the activation of ferroptosis promotes chondrocyte death and disrupts the ECM both in vivo and in vitro. In addition, FOXO3 can reduce OA progression by inhibiting ferroptosis through the NF-kappa B/MAPK signaling pathway. The Translational potential of this article: This study highlights the important role of chondrocyte ferroptosis regulated by FOXO3 through the NF-kappa B/MAPK signaling in the progression of OA. The inhibition of chondrocyte ferroptosis by activating FOXO3 is expected to be a new target for the treatment of OA.

FTH1 protects against osteoarthritis by inhibits ECM degradation via the MAPK pathway

FTH1 protects against osteoarthritis by MAPK pathway inhibition of extracellular matrix degradation

Reciprocal Inhibition of YAP/TAZ and NF-κB Regulates Osteoarthritic Cartilage Degradation

Targeting Fascin1 maintains chondrocytes phenotype and attenuates osteoarthritis development

Follistatin‐like Protein 1 (FSTL1) Promotes Chondrocyte Expression of Matrix Metalloproteinase and Inflammatory Factors Via the NF‐κB Pathway

TCF12 regulates the TGF-β/Smad2/3 signaling pathway to accelerate the progression of osteoarthritis by targeting CXCR4

TMF inhibits extracellular matrix degradation by regulating the C/EBPβ/ADAMTS5 signaling pathway in osteoarthritis

Astaxanthin Attenuates Osteoarthritis Progression Via Inhibiting Ferroptosis and Regulating Mitochondrial Function in Chondrocytes.

Forkhead Box O3 Attenuates Osteoarthritis by Suppressing Ferroptosis Through Inactivation of NF-κB/MAPK Signaling

Fibroblast growth factor 9 reduces TBHP-induced oxidative stress in chondrocytes and diminishes mouse osteoarthritis by activating ERK/Nrf2 signaling pathway

Nesfatin-1 suppresses interleukin-1 beta-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats

Downregulation of Extracellular Matrix Protein 1 Effectively Ameliorates Osteoarthritis Progression in Vivo.

A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult mice

The C5AR1/TNFSF13B axis alleviates osteoarthritis by activating the PI3K/Akt/GSK3β/Nrf2/HO-1 pathway to inhibit ferroptosis

Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression

Inhibition of transforming growth factor β-activated kinase 1 prevents inflammation-related cartilage degradation in osteoarthritis

Chondrocyte ferroptosis contribute to the progression of osteoarthritis

TUG1 Knockdown Promoted Viability and Inhibited Apoptosis and Cartilage ECM Degradation in Chondrocytes Via the Mir-17-5p/fut1 Pathway in Osteoarthritis.

Inflammation Triggers Chondrocyte Ferroptosis in TMJOA via HIF-1α/TFRC

Single cell RNA-seq analysis identifies ferroptotic chondrocyte cluster and reveals TRPV1 as an anti-ferroptotic target in osteoarthritis

Specific inhibition of FAK signaling attenuates subchondral bone deterioration and articular cartilage degeneration during osteoarthritis pathogenesis